Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Zhejiang Xianju Pharmaceutical Co., Ltd. (002332.SZ), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
22.46
P/B ratioShare price divided by book value per share.
1.43
P/S ratioMarket value divided by annual revenue.
2.25
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
11.70
EV / RevenueEnterprise value against annual revenue.
1.96
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
4.45%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
59.88%
Operating marginRevenue left after operating costs.
18.88%
Net marginRevenue left after every cost, including tax and interest.
10.03%
Return on equityProfit as a percentage of shareholders’ equity.
6.66%
Return on assetsProfit as a percentage of total assets.
3.78%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
3.67
Quick ratioThe same, excluding inventory.
2.58
Debt to equityTotal borrowings against shareholders’ equity.
0.03
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$0.39
Book value per shareShareholders’ equity divided by shares outstanding.
$6.14
Shares outstandingShares currently issued.
989,204,866
Market capitalisationShare price times shares outstanding.
$8.67B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
3,209
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
3.42%
Payout ratioShare of profit paid out as dividends.
What is Zhejiang Xianju Pharmaceutical Co., Ltd.'s P/E ratio?
Zhejiang Xianju Pharmaceutical Co., Ltd. (002332.SZ) trades on a price-to-earnings ratio of 22.46.
What is Zhejiang Xianju Pharmaceutical Co., Ltd.'s return on equity?
Zhejiang Xianju Pharmaceutical Co., Ltd. (002332.SZ) reports a return on equity of 6.66%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Zhejiang Xianju Pharmaceutical Co., Ltd. carry?
Zhejiang Xianju Pharmaceutical Co., Ltd. (002332.SZ) has a debt-to-equity ratio of 0.03, which compares total borrowings with shareholders' equity.
What is Zhejiang Xianju Pharmaceutical Co., Ltd.'s profit margin?
Zhejiang Xianju Pharmaceutical Co., Ltd. (002332.SZ) keeps 10.03% of revenue as net profit after every cost, including tax and interest.